August 14, 2020
Vicore Pharma publishes a prospectus for admission to trading of shares on Nasdaq Stockholm in connection with a directed share issue
Media
August 12, 2020
Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2020 results, Thursday 20 August
August 11, 2020
Fusion Pharmaceuticals Announces Second Quarter 2020 Financial Results And Business Update
August 11, 2020
Aprea Therapeutics Reports Second Quarter 2020 Financial Results and Provides Update on Business Operations
August 10, 2020
Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US
August 10, 2020
Nordic Nanovector Appoints Dr Christine Wilkinson Blanc as Chief Medical Officer
August 07, 2020
Oncopeptides initiates the first study with melflufen outside multiple myeloma and enrolls the first patient in the phase 1/2 AL amyloidosis study
August 06, 2020
Independent Review Committee Recommends Nordic Nanovector to focus on one dosage arm for the Pivotal PARADIGME Phase 2b Trial in Patients with 3L R/R FL
August 05, 2020
Fusion Pharmaceuticals To Present At The 2020 Wedbush PacGrow Healthcare Virtual Conference
August 05, 2020
Q2 2020 General Market Overview